AKT1 and glioblastoma: Interestingly, stimulation of fatty acid oxidation with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) is sufficient to sustain cell viability, indicating that activating Akt impairs the ability of GBM cells to metabolize non-glucose substrates, thus promoting glucose addiction.